2004
DOI: 10.1002/chin.200436268
|View full text |Cite
|
Sign up to set email alerts
|

Design of Chiral Ligands for Asymmetric Catalysis: From C2‐Symmetric P,P‐ and N,N‐Ligands to Sterically and Electronically Nonsymmetrical P,N‐Ligands

Abstract: For a long time, C2-symmetric ligands have dominated in asymmetric catalysis. More recently, nonsymmetrical modular P,N-ligands have been introduced. These ligands have been applied successfully in various metal-catalyzed reactions and, in many cases, have outperformed P,P-or N,N-ligands.M ost asymmetric catalysts that have been developed so far are metal complexes with chiral organic ligands. The chiral ligand modifies the reactivity and selectivity of the metal center in such a way that one of two possible e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(22 citation statements)
references
References 24 publications
0
22
0
Order By: Relevance
“…2,3 They are also the building blocks of life, imparting chirality on macrobiological structures of various conformations. 4,5 In both natural and synthetic stereoselective reactions, the use of one chiral molecule rather than its enantiomer can result in very different yields.…”
Section: Toc Graphicmentioning
confidence: 99%
“…2,3 They are also the building blocks of life, imparting chirality on macrobiological structures of various conformations. 4,5 In both natural and synthetic stereoselective reactions, the use of one chiral molecule rather than its enantiomer can result in very different yields.…”
Section: Toc Graphicmentioning
confidence: 99%
“…The result was a collection of complexes symmetrically and unsymmetrically substituted at the imine linkages. The use of unsymmetrical ligands for asymmetric induction has precedence in the literature ,,,. Figure displays the results for a set of complexes with unsymmetrical BINAM ligands.…”
Section: Resultsmentioning
confidence: 99%
“…In a more significant development, coated Fullerene particles might be deployed in vivo by injection, especially near the human brain and other parts of the central nervous system (Pfaltz and Drury, 2004;Krejcova et al, 2015). Targeted drug release might then be feasible to treat conditions near the body surface.…”
Section: In Vivo Applicationsmentioning
confidence: 99%